Market Place
Sourcing Support
Roche Prsent Ocrevus And Fenebrutinib Data at ECTRIMS 2025
24 Sep 2025 //
GLOBENEWSWIRE
Roche Reports Phase 3 Breast Cancer Victory for Oral Serd
24 Sep 2025 //
FIERCE BIOTECH
Genentech Appoints New Marketing Chief
18 Sep 2025 //
FIERCE PHARMA
Genentech`s Biologics Susvimo Receives Supple Approval in US
05 Sep 2025 //
FDA
Genentech`s Vabysmo Data Reinforce Efficacy, Safety in Wet AMD
05 Sep 2025 //
PHARMAWEB
Roche Makes Preclinical IBD Play in $420M+ OMass Pact
03 Sep 2025 //
BIOSPACE
Nykode Bets Future on Cancer Trial After Losing Genentech Pact
27 Aug 2025 //
FIERCE BIOTECH
Genentech, Roche Begin Construction on Advanced Manufacturing
25 Aug 2025 //
BUSINESSWIRE
Genentech Scraps $ 2B Deal with Cell Therapy Biotech
19 Aug 2025 //
FIERCE BIOTECH
Genentech’s Biologic Ocrevus Zunovo Receives Suppl Approval in US
18 Aug 2025 //
FDA
Genentech’s Biologics Tecentriq Receives Suppl Approval in US
18 Aug 2025 //
FDA
AZ, Genentech, Merck top oncology HCP promotions: report
14 Aug 2025 //
FIERCE PHARMA
Bicycle Cuts Staff as Genentech Ends R&D Pact
08 Aug 2025 //
FIERCE BIOTECH
Genentech Susvimo Maintains Vision 5 Years in Wet AMD Patients
01 Aug 2025 //
BUSINESSWIRE
Roche`s Alzheimer`s Antibody Reduces Amyloid Plaques in 7 Months
28 Jul 2025 //
BIOSPACE
Global Alzheimer Platform, Genentech Partner for Research Access
28 Jul 2025 //
GLOBENEWSWIRE
Genentech Downsizes by 87 as Priorities Shift
24 Jul 2025 //
BIOSPACE
Genentech Axes 87 Jobs in Latest HQ Layoffs Round
23 Jul 2025 //
FIERCE BIOTECH
Genentech’s Biologics Nutropin AQ Receives Suppl Approval
09 Jul 2025 //
FDA
Genentech`s Biologics Hemlibra Receive Suppl Approval in US
08 Jul 2025 //
FDA
Genentech’s Biologics Perjeta Receives Suppl Approval in US
27 Jun 2025 //
FDA
Genentech Provides Update on Phase III Verona Study
16 Jun 2025 //
BUSINESSWIRE
Genentech`s Itovebi Extends Survival in HR-positive Breast Cancer
31 May 2025 //
BUSINESSWIRE
Genentech`s Columvi Extends Survival in Lymphoma Patients
23 May 2025 //
BUSINESSWIRE
FDA Approves Genentech`s Susvimo for Diabetic Retinopathy
22 May 2025 //
BUSINESSWIRE
Genentech Bets Again on Orionis With $2B+ in Glue Space
22 May 2025 //
BIOSPACE
Genentech`s Biologics Susvimo Receives Suppl Approval in US
21 May 2025 //
FDA
Genentech Update on FDA Meeting for Columvi in Lymphoma
20 May 2025 //
BUSINESSWIRE
Genentech`s Biologics Piasky Receives Suppl Approval in US
14 May 2025 //
FDA
Genentech honors hemophilia A caregivers in Hemlibra short film
14 May 2025 //
FIERCE PHARMA
10-Year Data: Perjeta Regimen Cuts Breast Cancer Deaths
13 May 2025 //
BUSINESSWIRE
NEJM: Single-dose Xofluza Reduces Influenza Transmission
25 Apr 2025 //
BUSINESSWIRE
Genentech builds autoimmune Repertoire with $765M deal
24 Apr 2025 //
FIERCE BIOTECH
Genentech and Roche reveal Alzheimer`s advancements at AD/PD 2025
03 Apr 2025 //
BUSINESSWIRE
Genentech Updates Ocrevus High Dose Study in Multiple Sclerosis
02 Apr 2025 //
BUSINESSWIRE
Roche Launches Genentech Innovation Center In Boston
07 Mar 2025 //
GLOBENEWSWIRE
FDA Accepts sBLA For Genentech’s Gazyva In Lupus Nephritis
06 Mar 2025 //
BUSINESSWIRE
FDA Approves Genentech’s TNKase® in Acute Ischemic Stroke in Adults
04 Mar 2025 //
PRESS RELEASE
Kineta sells Genentech, Merck deals to investor ahead of merger
11 Feb 2025 //
FIERCE BIOTECH
Genentech’s Gazyva Shows Superiority in Active Lupus Nephritis
07 Feb 2025 //
BUSINESSWIRE
FDA Approves Roche’s Susvimo in Diabetes-related Blindness
04 Feb 2025 //
GLOBENEWSWIRE
Genentech`s Biologic Susvimo Receives Suppl Approval in US
04 Feb 2025 //
FDA
Genentech Itovebi Show Survival Benefit In HR+ve Breast Cancer
28 Jan 2025 //
BUSINESSWIRE
Genentech’s Itovebi Shows Survival Benefit in Breast Cancer
27 Jan 2025 //
BUSINESSWIRE
Genprex Doses Patient In Acclaim-3 Phase 2 Study For Lung Cancer
23 Jan 2025 //
PR NEWSWIRE
Genentech’s Prasinezumab Ph IIb Miss Primary Endpoint in Parkinson
19 Dec 2024 //
BUSINESSWIRE
Genentech’s Polivy Combo is New Standard for Untreated Lymphoma
09 Dec 2024 //
BUSINESSWIRE
Genentech Updates Columvi, Lunsumio Data at ASH 2024 for Lymphoma
09 Dec 2024 //
BUSINESSWIRE
FDA Accepts sBLA For Genentech`s Columvi Combo For R/R DLBCL
05 Dec 2024 //
BUSINESSWIRE
COUR Signs Licensing Deal with Genentech for Autoimmune Therapy
03 Dec 2024 //
GLOBENEWSWIRE
Genentech Reports Update on Phase III SKYSCRAPER-01 Study Results
26 Nov 2024 //
BUSINESSWIRE
Genentech`s Biologic Lunsumio Receives Suppl Approval in US
22 Nov 2024 //
FDA
Onco360 Named National Pharmacy Partner for Itovebi™
11 Nov 2024 //
GLOBENEWSWIRE
Genentech axes Nykode cancer vaccine deal
09 Nov 2024 //
FIERCE BIOTECH
Genentech to Share Long-term Data at ASH 2024 Hematology
05 Nov 2024 //
BUSINESSWIRE
Genentech’s Itovebi Shows Landmark Phase 3 Results in Breast Cancer
30 Oct 2024 //
BUSINESSWIRE
Roche MAGE-A4 trial withdrawn after strategic review
19 Oct 2024 //
FIERCE BIOTECH
Genentech’s Vabysmo Improves Vision In DME Underrepresented Groups
18 Oct 2024 //
BUSINESSWIRE
Jazz`s almost-withdrawn lung cancer drug shows life
16 Oct 2024 //
PR NEWSWIRE
Roche`s Evrysdi Shows Positive Results In Children With SMA
14 Oct 2024 //
GLOBENEWSWIRE
